60 Degrees Pharmaceuticals (NASDAQ:SXTP) announced on April 15, 2026, a strategic partnership with Runway Health to make ARAKODA (tafenoquine) available to U.S. travelers via a dedicated telehealth platform.
Immutep (NASDAQ:IMMP), a clinical-stage biotechnology company developing LAG-3 immunotherapies, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, eftilagimod alfa (efti), for the treatment of soft tissue sarcoma (STS).
NOV (NYSE:NOV) announced today that it has lowered its financial guidance for the first quarter of 2026, citing unforeseen operational and logistical disruptions caused by the escalating conflict in the Middle East.
Arbutus Biopharma (NASDAQ:ABUS), a clinical-stage biopharmaceutical company specializing in chronic infectious diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for imdusiran (AB-729) for the treatment of chronic hepatitis B (cHBV).
Bitdeer Technologies Group (NASDAQ:BTDR) has released its operational update for March 2026, highlighting a period of hyper-growth in both its artificial intelligence infrastructure and core Bitcoin mining operations.
Mako Mining (NASDAQ:MAKO) has announced record-breaking production results for the first quarter ended March 31, 2026, marking a pivotal shift in the company’s financial and operational trajectory.
Arrive AI (NASDAQ:ARAI), a developer of autonomous delivery infrastructure and the "smart mailbox" for the drone era, has reported its financial results for the full year and fourth quarter ended December 31, 2025.
Morgan Stanley (NYSE:MS) reported record financial results for the first quarter ended March 31, 2026, characterized by significant growth across its core business segments.
Labcorp (NYSE:LH), a global leader in innovative laboratory services, has announced the launch of the Labcorp Fentanyl Urine Visual Test.
Aurora Cannabis (NASDAQ:ACB) has announced the acquisition of Safari Flower Company for a total consideration of $26.5 million, a strategic move designed to significantly expand its European Union Good Manufacturing Practice (EU GMP) cultivation and manufacturing capacity.
Vince Holding (NASDAQ:VNCE) reported financial results for the fourth quarter and fiscal year ended January 31, 2026, revealing a complex performance marked by top-line growth and significant one-time headwinds.
Spire (NYSE:SR) has entered into a definitive agreement to sell its natural gas storage assets located in Wyoming and Oklahoma to I Squared Capital for a total consideration of $650 million.
